Research classified by Journal of Economic Literature (JEL) codes

2026

• Charles Gray & Abby Alpert & Neeraj Sood, 2026, "Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market," American Economic Journal: Applied Economics, American Economic Association, volume 18, issue 1, pages 286-304, January, DOI: 10.1257/app.20240011.
• Akyildirim, Erdinc & Corbet, Shaen & Muñiz, Jose Antonio & Scrimgeour, Frank, 2026, "Market perceptions of ESG reputational risk in the US pharmaceutical industry," LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library, number 137054, Feb.
• Maryam Sadighi & Jean-Pierre Ponssard & Maria Eugenia Sanin & Murès Zarea & Elodie Le Cadre Loret, 2026, "Sectoral Cost-Benefit Analysis for Clean Technology Demonstrators: Insights for Decarbonizing Hard-to-Abate Industries," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, volume 89, issue 2, pages 1-36, February, DOI: 10.1007/s10640-025-01051-4.
• Cesar Barraza-Botet & Daniel Nadal & Maya Rosen & David Winickoff, 2026, "A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States," OECD Science, Technology and Industry Working Papers, OECD Publishing, number 2026/02, Jan.
• Josh Feng & Matthew J. Higgins & Elena Patel, 2026, "Pediatric Drug Adherence and Parental Attention: Evidence From Comprehensive Claims Data," Health Economics, John Wiley & Sons, Ltd., volume 35, issue 2, pages 346-359, February, DOI: 10.1002/hec.70062.

2025

• Amanda Starc & Thomas G. Wollmann, 2025, "Does Entry Remedy Collusion? Evidence from the Generic Prescription Drug Cartel," American Economic Review, American Economic Association, volume 115, issue 5, pages 1400-1438, May, DOI: 10.1257/aer.20220276.
• Melissa Newham & Jo Seldeslachts & Albert Banal-Estañol, 2025, "Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry," American Economic Journal: Microeconomics, American Economic Association, volume 17, issue 4, pages 260-327, November, DOI: 10.1257/mic.20220220.
• Carl Shapiro, 2025, "Acquisitions to Enter New Markets," Journal of Economic Perspectives, American Economic Association, volume 39, issue 1, pages 53-76, Winter, DOI: 10.1257/jep.20241414.
• C. Scott Hemphill & Bhaven N. Sampat, 2025, "Patents, Innovation, and Competition in Pharmaceuticals: The Hatch-Waxman Act after 40 Years," Journal of Economic Perspectives, American Economic Association, volume 39, issue 2, pages 27-52, Spring, DOI: 10.1257/jep.20241423.
• Craig Garthwaite, 2025, "Economic Markets and Pharmaceutical Innovation," Journal of Economic Perspectives, American Economic Association, volume 39, issue 2, pages 3-26, Spring, DOI: 10.1257/jep.20251438.
• Margaret K. Kyle, 2025, "Lessons for the United States from Pharmaceutical Regulation Abroad," Journal of Economic Perspectives, American Economic Association, volume 39, issue 2, pages 53-78, Spring, DOI: 10.1257/jep.20241418.
• Rena M. Conti & Marta E. Wosińska, 2025, "The Economics of Generic Drug Shortages: The Limits of Competition," Journal of Economic Perspectives, American Economic Association, volume 39, issue 2, pages 79-102, Spring, DOI: 10.1257/jep.20241420.
• Cristian Moisoiu & Constantin Ciupagea & Stefan-Radu Oprea & Razvan Pircalabescu, 2025, "The Technologies of the Future in the Field of Fertilisers and Romania’s Opportunities to Recover this Industry," The AMFITEATRU ECONOMIC journal, Academy of Economic Studies - Bucharest, Romania, volume 27, issue 69, pages 688-688, April.
• Rossana Mastrandrea & Fabio Montobbio & Gabriele Pellegrino & Massimo Riccaboni & Valerio Sterzi, 2025, "Leveraging Knowledge Networks: Rethinking Technological Value Distribution in mRNA Vaccine Innovations," Papers, arXiv.org, number 2503.14072, Mar.
• António André Chivanga Barros & Feliciano José Ricardo Cangue & Vinicyus Rodolfo Wiggers & Fernando Darci Pitt, 2025, "Polymerization of purified residual glycerol from biodiesel production," Cognitive Sustainability, Cognitive Sustainability Ltd., volume 4, issue 1, pages 60-77, March, DOI: 10.55343/CogSust.137.
• Rossana Mastrandrea & Fabio Montobbio & Gabriele Pellegrino & Massimo Riccaboni & Valerio Sterzi, 2025, "Leveraging Knowledge Networks: Rethinking Technological Value Distribution in mRNA Vaccine Innovations," DISCE - Working Papers del Dipartimento di Politica Economica, Università Cattolica del Sacro Cuore, Dipartimenti e Istituti di Scienze Economiche (DISCE), number dipe0047, Mar.
• Claus Michelsen, 2025, "Ungesunde Abhängigkeiten: Die Risiken für die Versorgung mit Medikamenten nehmen zu," Vierteljahreshefte zur Arbeits- und Wirtschaftsforschung, Duncker & Humblot, Berlin, volume 2, issue 1, pages 7-21, DOI: 10.3790/vaw.2.1.7.
• Jan Malek & Jo Seldeslachts & Reinhilde Veugelers, 2025, "Are M&As Spurring or Stifling Innovation? Evidence from Antidiabetic Drug Development," Discussion Papers of DIW Berlin, DIW Berlin, German Institute for Economic Research, number 2128.
• Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2025, "Taking the competitor’s pill: When combination therapies enter pharmaceutical markets," Journal of Health Economics, Elsevier, volume 101, issue C, DOI: 10.1016/j.jhealeco.2025.102976.
• Miao, Yang & Tian, Yule & Cao, Jian & Yu, Xinqi, 2025, "Green finance and privatization of green projects in the fossil fuels industry," Resources Policy, Elsevier, volume 103, issue C, DOI: 10.1016/j.resourpol.2025.105547.
• Learmouth, Tom, 2025, "Upgrading traditional industries in interwar Japan: from cotton tabi to Bridgestone tyres," LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library, number 130283, Nov.
• Learmouth, Tom, 2025, "Upgrading traditional industries in interwar Japan: from cotton tabi to Bridgestone tyres," Economic History Working Papers, London School of Economics and Political Science, Department of Economic History, number 130283, Nov.
• Fujii-Gambero, Gerardo & Morales-López, Rodrigo, 2025, "Precio unitario de las exportaciones intensivas en recursos naturales de Argentina, Brasil, Chile, México, Perú y Venezuela, según el nivel de procesamiento manufacturero," El Trimestre Económico, Fondo de Cultura Económica, volume 92, issue 366, pages 347-380, April-Jun, DOI: https://doi.org/10.20430/ete.v92i36.
• Pawel Jaskula & Jacek Miedziak, 2025, "Methods of Skin Decontamination Following Exposure to Toxic Industrial Chemicals and Chemical Warfare Agents," European Research Studies Journal, European Research Studies Journal, volume 0, issue 4, pages 1869-1883.
• Jan Malek & Jo Seldeslachts & Reinhilde Veugelers, 2025, "Are M&As spurring or stifling innovation? Evidence from antidiabetic drug development," Working Papers of Department of Management, Strategy and Innovation, Leuven, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven, number 768578, Jul.
• Abdelaaziz Lekbich, 2025, "Perceived Quality of Information Systems and Logistics Performance: A Behavioral Approach in the Moroccan Pharmaceutical Sector
  [Qualité perçue des systèmes d'information et performance logistique : une approche comportementale appliquée au secteu," Post-Print, HAL, number hal-05226207, Aug, DOI: 10.5281/zenodo.16963287.
• Abdelaaziz Lekbich, 2025, "Information Systems and Organizational Embedding: An Analysis of Technical and Structural Success Factors
  [Systèmes d'Information et ancrage organisationnel : Analyse des facteurs techniques et structurels de réussite]," Post-Print, HAL, number hal-05246698, Sep, DOI: 10.5281/zenodo.17084954.
• Pierre Dubois & Gosia Majewska & Valentina Reig, 2025, "Drug shortages: empirical evidence from France," Working Papers, HAL, number hal-05317931, Oct.
• Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2025, "Competition matters: uniform vs. indication-based pricing of pharmaceuticals," Discussion Paper Series in Economics, Norwegian School of Economics, Department of Economics, number 1/2025, Jan.
• Catherine Nemeskal, 2025, "Uncovering the Impact of FDA Accelerated Approval on Biotechnology Companies," Atlantic Economic Journal, Springer;International Atlantic Economic Society, volume 53, issue 4, pages 347-349, December, DOI: 10.1007/s11293-025-09844-0.
• Yong Cai & Qiang Liu & Yunlong Wang & Fan Zhang, 2025, "Predicting rare events in markets with relational data," Quantitative Marketing and Economics (QME), Springer, volume 23, issue 4, pages 545-588, December, DOI: 10.1007/s11129-025-09302-w.
• Haruo Kakehi & Ryo Nakajima, 2025, "Role of Pharmacists in Generic Pharmaceutical Adoption," Keio-IES Discussion Paper Series, Institute for Economics Studies, Keio University, number 2025-001, Jan.
• Michael D. Frakes & Melissa F. Wasserman, 2025, "Strategic Patenting: Evidence from the Biopharmaceutical Industry," NBER Working Papers, National Bureau of Economic Research, Inc, number 34024, Jul.
• Eric Budish & Maya M. Durvasula & Benjamin N. Roin & Heidi L. Williams, 2025, "Missing Markets for Innovation: Evidence from New Uses for Existing Drugs," NBER Working Papers, National Bureau of Economic Research, Inc, number 34222, Sep.
• Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2025, "Competition matters: uniform vs. indication-based pricing of pharmaceuticals," NIPE Working Papers, NIPE - Universidade do Minho, number 1/2025.
• Elena Stefanova, 2025, "Traditions and Current Aspects in the Development of the Chemical Industry in Bulgaria," Ikonomiceski i Sotsialni Alternativi, University of National and World Economy, Sofia, Bulgaria, issue 3, pages 20-38, December.
• Elena Stefanova, 2025, "Trends and Perspectives in the Development of Pharmaceutical Production in Bulgaria," Ikonomiceski i Sotsialni Alternativi, University of National and World Economy, Sofia, Bulgaria, issue 2, pages 29-46, July.
• Andrew Brown & Frithjof Laubinger & Peter Börkey, 2025, "Monitoring trade in plastic waste and scrap 2025," OECD Environment Working Papers, OECD Publishing, number 259, May.
• Douglas K. R. Robinson & Daniel Nadal, 2025, "Synthetic biology in focus: Policy issues and opportunities in engineering life," OECD Science, Technology and Industry Working Papers, OECD Publishing, number 2025/03, Feb.
• Oecd, 2025, "Synthetic biology, AI and automation: A forward-looking technology assessment," OECD Science, Technology and Industry Policy Papers, OECD Publishing, number 187, Dec.
• Tan Ke Wen, Carmen, 2025, "Study on National Industrialization Co. In Saudi Arabia: Operational Efficiency and Its Determinants from 2013 to 2023," MPRA Paper, University Library of Munich, Germany, number 123238, Jan.
• Koski, Heli, 2025, "Privacy Regulation and R&D Investments: Causal Evidence from Global Pharmaceutical and Biotechnology Firms," ETLA Working Papers, The Research Institute of the Finnish Economy, number 130, Aug.
• Kyung In Hwang & Hana Hankyeol Kwon, 2025, "Sustainability for Survival: Strategies for Korean Batterymakers in the European Market," Industrial Economic Review, Korea Institute for Industrial Economics and Trade, number 24-29, Feb.
• Sangwon Lee, 2025, "The Competitiveness of Korea’s Fine Chemicals Industry," Industrial Economic Review, Korea Institute for Industrial Economics and Trade, number 25-2, Feb.
• Byungyul Park, 2025, "Building Resilient Automotive Supply Chains through Cooperation with India," Industrial Economic Review, Korea Institute for Industrial Economics and Trade, number 25-14, Apr.
• Kyung-In Hwang, 2025, "The impact of the OBBBA on the South Korean battery sector," Research Papers, Korea Institute for Industrial Economics and Trade, number 021836, Jul.
• Cho Chuel, 2025, "Major Issues in the EV and Battery Industries, with Implications for Korean Policy," Research Papers, Korea Institute for Industrial Economics and Trade, number 24/10, Aug.
• Aleksandar Erceg & Jovana Damoska Sekuloska & Vera Boškovska, 2025, "Industry Symbiosis – Literature Review And Situation In North Macedonia," UTMS Journal of Economics, University of Tourism and Management, Skopje, Macedonia, volume 16, issue 1, pages 11-29, June.
• Germà Bel & Joël Bühler, 2025, "The effect of Door-to-Door on separate collection of plastic packaging: evidence from Catalonia," Environmental Economics and Policy Studies, Springer;Society for Environmental Economics and Policy Studies - SEEPS, volume 27, issue 3, pages 377-403, July, DOI: 10.1007/s10018-024-00428-x.
• Hirotaka Kumamaru & Kenji Takeuchi, 2025, "Less plastic, more profits? Estimating the effect of firms’ efforts for plastic reduction on their financial performance," Environmental Economics and Policy Studies, Springer;Society for Environmental Economics and Policy Studies - SEEPS, volume 27, issue 3, pages 511-525, July, DOI: 10.1007/s10018-025-00449-0.
• Arielle D’Souza & Kendall Hoyt & Christopher M. Snyder & Alec Stapp, 2025, "Can Operation Warp Speed Serve as a Model for Accelerating Innovations beyond COVID Vaccines?," Entrepreneurship and Innovation Policy and the Economy, University of Chicago Press, volume 4, issue 1, pages 103-138, DOI: 10.1086/732855.
• Klecka Jiri & Scholleová Hana & Camska Dagmar, 2025, "Economic Impacts of Technique Substitution in Chemistry due to Industry 4.0," Management Theory and Studies for Rural Business and Infrastructure Development, Sciendo, volume 47, issue 2, pages 174-186, DOI: 10.15544/mts.2025.14.
• Bouzidi Abdelbasset & Bedaida Imad Eddine & Belimane Wissam, 2025, "Risk Management Applying FMECA in Pharmaceutical Packaging Production: Implementation of ISO 15378:2017 – Case Study," Timisoara Journal of Economics and Business, Sciendo, volume 18, issue 1, pages 95-112, DOI: 10.2478/tjeb-2025-0005.
• Samadi, Sascha & Fischer, Andreas & Verpoort, Philipp C. & Müller-Hansen, Finn & Ueckerdt, Falko, 2025, "Synthesising Current Knowledge on the Renewables Pull: A Systematic Literature Review," EconStor Conference Papers, ZBW - Leibniz Information Centre for Economics, number 331736.
• Nyeleti Mayimele, Nsovo, 2025, "Women Leaders in the Strategic Positions of Pharmaceutical Companies: Overcoming Barriers and Systemic Biases," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, volume 9, issue 1, pages 65-78, DOI: 10.61093/bel.9(1).65-78.2025.
• Hager, Sandy Brian, 2025, "The Shifting Fortunes of Corporate Psychedelia," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, pages 1-23, DOI: 10.1017/fas.2025.10014.
• Kirchhoff, Jasmina & Koppel, Oliver, 2025, "Pharmastandort Deutschland im Innovationswettbewerb: Patentaktivitäten im internationalen Vergleich Jasmina Kirchhoff/Oliver Koppel," IW-Trends – Vierteljahresschrift zur empirischen Wirtschaftsforschung, Institut der deutschen Wirtschaft (IW) / German Economic Institute, volume 52, issue 1, pages 63-83, DOI: 10.2373/1864-810X.25-01-04.
• Voss, Simon, 2025, "Do Homeless Shelters Increase Local Crime? Evidence from Los Angeles," VfS Annual Conference 2025 (Cologne): Revival of Industrial Policy, Verein für Socialpolitik / German Economic Association, number 325469.

2024

• Juan Pablo Atal & José Ignacio Cuesta & Felipe González & Cristóbal Otero, 2024, "The Economics of the Public Option: Evidence from Local Pharmaceutical Markets," American Economic Review, American Economic Association, volume 114, issue 3, pages 615-644, March, DOI: 10.1257/aer.20211547.
• Abby Alpert & Sarah Dykstra & Mireille Jacobson, 2024, "Hassle Costs versus Information: How Do Prescription Drug Monitoring Programs Reduce Opioid Prescribing?," American Economic Journal: Economic Policy, American Economic Association, volume 16, issue 1, pages 87-123, February, DOI: 10.1257/pol.20200579.
• Leemore Dafny & Kate Ho & Edward Kong, 2024, "How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?," American Economic Journal: Economic Policy, American Economic Association, volume 16, issue 3, pages 314-346, August, DOI: 10.1257/pol.20220355.
• Shengmao Cao & Lisa Xuejie Yi & Chuan Yu, 2024, "Competitive Bidding in Drug Procurement: Evidence from China," American Economic Journal: Economic Policy, American Economic Association, volume 16, issue 3, pages 481-513, August, DOI: 10.1257/pol.20220505.
• Mireille Jacobson & David Powell, 2024, "Price Sensitivity and Information Barriers to the Take-up of Naloxone," American Economic Journal: Economic Policy, American Economic Association, volume 16, issue 4, pages 463-490, November, DOI: 10.1257/pol.20230135.
• Alexander B. Gusev & Maksim A. Yurevich, 2024, "Economies of Scale in The Russian Pharmaceutical Industry: Empirical Assessments," Journal of Applied Economic Research, Graduate School of Economics and Management, Ural Federal University, volume 23, issue 4, pages 1055-1076, DOI: https://doi.org/10.15826/vestnik.20.
• Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulmac & Deniz Unal, 2024, "Pioneering a New Classification: a Comprehensive Study of Healthcare Products in Global Trade," Working papers, Banque de France, number 963.
• Claudio Deiana & Ludovica Giua & Roberto Nisticò, 2024, "Opium Price Shocks and Prescription Opioids in the USA," Oxford Bulletin of Economics and Statistics, Department of Economics, University of Oxford, volume 86, issue 3, pages 449-484, June, DOI: 10.1111/obes.12584.
• Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2024, "Competing with precision: incentives for developing predictive biomarker tests," Scandinavian Journal of Economics, Wiley Blackwell, volume 126, issue 1, pages 60-97, January, DOI: 10.1111/sjoe.12543.
• Weder, Rolf & Bentele, Riccardo, 2024, "On the Importance of Swiss Patient Data for Pharmaceutical R&D in Switzerland," Working papers, Faculty of Business and Economics - University of Basel, number 2024/02.
• Congressional Budget Office, 2024, "Alternative Approaches to Reducing Prescription Drug Prices," Reports, Congressional Budget Office, number 58793, Oct.
• Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulman & Deniz Ünal, 2024, "Pioneering a new classification: a comprehensive study of healthcare products in global trade," Working Papers, CEPII research center, number 2024-02, Jan.
• Sebastián Sztulwark & Valentina Locher & Pablo Wahren & Melisa Girard, 2024, "Transición paradigmática en la industriaagro-biotecnológica mundial," Ensayos de Economía, Universidad Nacional de Colombia Sede Medellín, number 21230, Nov.
• Malek, Jan & Newham, Melissa & Seldeslachts, Jo & Veugelers, Reinhilde, 2024, "Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development," CEPR Discussion Papers, C.E.P.R. Discussion Papers, number 18816, Feb.
• Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulman & Deniz Ünal, 2024, "Pioneering a new classification: a comprehensive study of healthcare products in global trade," Working Papers, DIAL (Développement, Institutions et Mondialisation), number DT/2024/01, Jan.
• Jo Seldeslachts & Jan Malek & Melissa Newham & Reinhilde Veugelers, 2024, "Übernahmen in der Pharmaindustrie: Fokus mehr auf Innovationsmärkte als auf Marktverdrängung richten," DIW Wochenbericht, DIW Berlin, German Institute for Economic Research, volume 91, issue 37, pages 579-585.
• Jan Malek & Melissa Newham & Jo Seldeslachts & Reinhilde Veugelers, 2024, "Acquiring R&D Projects: Who, When, and What? Evidence from Antidiabetic Drug Development," Discussion Papers of DIW Berlin, DIW Berlin, German Institute for Economic Research, number 2073.
• Xi Sun & Sophie M. Behr & Merve Kücük, 2024, "Enabling Circular Economy Dynamics in the Plastics and Steel Industries: Perspectives from Multiple Stakeholders," Discussion Papers of DIW Berlin, DIW Berlin, German Institute for Economic Research, number 2093.
• Wan, Paijie & He, Feng & Zhang, Hongjie, 2024, "Can the separation of marketing authorization from manufacturing authorization stimulate pharmaceutical innovation? Evidence from China's pharmaceutical industry reform," Economic Analysis and Policy, Elsevier, volume 83, issue C, pages 734-748, DOI: 10.1016/j.eap.2024.07.020.
• Cheng, Haotian & Ng'ombe, John N. & Lambert, Dayton M., 2024, "A Bayesian generalized rank ordered logit model," Journal of choice modelling, Elsevier, volume 50, issue C, DOI: 10.1016/j.jocm.2024.100475.
• Bokhari, Farasat A.S. & Mariuzzo, Franco & Yan, Weijie, 2024, "Antibacterial resistance and the cost of affecting demand: The case of UK antibiotics," International Journal of Industrial Organization, Elsevier, volume 95, issue C, DOI: 10.1016/j.ijindorg.2024.103082.
• Cotterlaz, Pierre & Gaulier, Guillaume & Sztulman, Aude & Ünal, Deniz, 2024, "Broadening the definition of healthcare products in global trade: Insights from a new classification," International Economics, Elsevier, volume 180, issue C, DOI: 10.1016/j.inteco.2024.100561.
• Sarig, Oren, 2024, "Pharmaceutical demand response to utilization management," Journal of Health Economics, Elsevier, volume 93, issue C, DOI: 10.1016/j.jhealeco.2023.102830.
• Hermosilla, Manuel, 2024, "Regulating ethical experimentation: Impacts of the breakthrough therapy designation on drug R&D," Journal of Health Economics, Elsevier, volume 94, issue C, DOI: 10.1016/j.jhealeco.2023.102855.
• Scheibe, Andrew & Shelly, Shaun & Stowe, M. J., 2024, "Insights into the value of the market for cocaine, heroin and methamphetamine in South Africa," LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library, number 122162, Feb.
• Fujii-Gambero, Gerardo & Morales-López, Rodrigo, 2024, "Calidad de las exportaciones manufactureras de México en el contexto de fragmentación internacional de la producción," El Trimestre Económico, Fondo de Cultura Económica, volume 91, issue 361, pages 7-46, enero-mar, DOI: https://doi.org/10.20430/ete.v91i36.
• Sucharita Bhattacharyya & Bibek Ray Chaudhuri & Susmita Chatterjee & Debashis Chakraborty, 2024, "Pharmaceutical exports and patents in India – a systems approach," Indian Growth and Development Review, Emerald Group Publishing Limited, volume 17, issue 3, pages 341-360, May, DOI: 10.1108/IGDR-11-2022-0128.
• Jan Malek & Melissa Newham & Jo Seldeslachts & Reinhilde Veugelers, 2024, "Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development," Working Papers of Department of Management, Strategy and Innovation, Leuven, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven, number 735739, Feb.
• Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulman & Deniz Ünal, 2024, "Broadening the definition of healthcare products in global trade: Insights from a new classification," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers), HAL, number hal-04904344, Dec, DOI: 10.1016/j.inteco.2024.100561.
• Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulman & Deniz Ünal, 2024, "Broadening the definition of healthcare products in global trade: Insights from a new classification," Post-Print, HAL, number hal-04904344, Dec, DOI: 10.1016/j.inteco.2024.100561.
• Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulman & Deniz Ünal, 2024, "Broadening the definition of healthcare products in global trade: Insights from a new classification," Sciences Po Economics Publications (main), HAL, number hal-04904344, Dec, DOI: 10.1016/j.inteco.2024.100561.
• Germà Bel & Joël Bühler, 2024, "The Effect of Door-to-Door on Separate Collection of Plastic Packaging: Evidence from Catalonia," IREA Working Papers, University of Barcelona, Research Institute of Applied Economics, number 202410, Feb, revised Feb 2024.
• Yassin Mwachande & Kotie Viljoen & Marinda Pretorius, 2024, "The Impact of the National Export Strategy on the Plastics and Packaging Industry in Malawi," Journal of Developing Areas, Tennessee State University, College of Business, volume 58, issue 4, pages 241-254, October–D.
• Konstantinos N. Baltas & Robert Mann & Nicholaos C. Baltas, 2024, "The COVID-19 Pandemic and Unsustainable PPE Materials: A Correlation and Causality Analysis," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, volume 87, issue 6, pages 1651-1671, June, DOI: 10.1007/s10640-024-00870-1.
• Marisol Carvajal-Camperos & Paloma Almodóvar & Ignacio Danvila-del-Valle, 2024, "Examining the conditions for signing a strategic alliance contract: a configurational approach to the biotechnology sector," The Journal of Technology Transfer, Springer, volume 49, issue 1, pages 44-68, February, DOI: 10.1007/s10961-022-09983-5.
• Haruo Kakehi & Ryo Nakajima, 2024, "Role of Pharmacists in Generic Pharmaceutical Adoption," Keio-IES Discussion Paper Series, Institute for Economics Studies, Keio University, number 2024-015, Jun.
• Arielle D'Souza & Kendall Hoyt & Christopher M. Snyder & Alec Stapp, 2024, "Can Operation Warp Speed Serve as a Model for Accelerating Innovations beyond COVID Vaccines?," NBER Chapters, National Bureau of Economic Research, Inc, "Entrepreneurship and Innovation Policy and the Economy, volume 4".
• Rachel Glennerster & Thomas Kelly & Claire T. McMahon & Christopher M. Snyder, 2024, "Quantifying the Social Value of a Universal COVID-19 Vaccine and Incentivizing Its Development," NBER Working Papers, National Bureau of Economic Research, Inc, number 32059, Jan.
• Phares Akari & Chirantan Chatterjee & Matthew J. Higgins, 2024, "Don’t Throw the Baby Out With the Bathwater: Firm Response to Downstream Product Shocks," NBER Working Papers, National Bureau of Economic Research, Inc, number 32703, Jul.
• Arielle D'Souza & Kendall Hoyt & Christopher M. Snyder & Alec Stapp, 2024, "Can Operation Warp Speed Serve as a Model for Accelerating Innovations Beyond COVID Vaccines?," NBER Working Papers, National Bureau of Economic Research, Inc, number 32831, Aug.
• Rachel Glennerster & Catherine Che & Sarrin M. Chethik & Claire T. McMahon & Christopher M. Snyder, 2024, "Investing in Vaccines to Mitigate Harm from COVID-19 and Future Pandemics," NBER Working Papers, National Bureau of Economic Research, Inc, number 32984, Sep.
• Marjolijn Moens & Eliana Barrenho & Valérie Paris, 2024, "Exploring the feasibility of sharing information on medicine prices across countries," OECD Health Working Papers, OECD Publishing, number 171, Sep, DOI: 10.1787/5e4a7a47-en.
• Bum Cheul Park & Andrew Brown & Frithjof Laubinger & Peter Börkey, 2024, "Monitoring trade in plastic waste and scrap 2024," OECD Environment Working Papers, OECD Publishing, number 233, Apr, DOI: 10.1787/013bcfdd-en.
• Eun Kyo Cho, 2024, "Changes and Implications of China’s High-tech Industry Development Policy after the US-China Conflict," Industrial Economic Review, Korea Institute for Industrial Economics and Trade, number 24-2, Feb.
• Sung Keun Park & Sungwoo Kang & Jung Min Han, 2024, "Changes in the Global Income Elasticity of South Korean Exports, with Implications for Policy," i-KIET Issues and Analysis, Korea Institute for Industrial Economics and Trade, number 24/4, Sep.
• Dongsoo Kim, 2024, "From Dependence to Partnership: Korea's Quest for Supply Chain Stability in Critical Mineral Resources," Research Papers, Korea Institute for Industrial Economics and Trade, number 24/1, Feb.
• Kye Hwan Kim & Jooyoung Yang & Eun Kyo Cho, 2024, "Korea in the Tech Crossfire: Strategic Responses to the US-China Decoupling in Batteries and Semiconductors," Research Papers, Korea Institute for Industrial Economics and Trade, number 24/2, Feb.
• Kyung In Hwang, 2024, "The EV Chasm and Korea’s Battery Sector: A Deep Dive into the Current Slump," Research Papers, Korea Institute for Industrial Economics and Trade, number 24/11, Nov.
• Avdasheva, Svetlana (Авдашева, Светлана) & Khomik, Olesya (Хомик, Олеся) & Yusupova, Gyuzel (Юсупова, Гюзель), 2024, "Improving Compliance With Antitrust Measures Through Commercial Policies
  [Коммерческие Политики Как Форма Антимонопольного Комплаенса (На Примере Фармацевтических Компаний)]," Ekonomicheskaya Politika / Economic Policy, Russian Presidential Academy of National Economy and Public Administration, volume 19, issue 2, pages 6-35, DOI: 10.18288/1994-5124-2024-2-6-35.
• Shailender Kumar Hooda, 2024, "Exploring the Growth Dynamics of India's Medical Device Industry: Key Issues and Challenges," Working Papers, Institute for Studies in Industrial Development (ISID), number 290a, Dec.
• Vinish Kathuria & Rajesh Raj Natarajan, 2024, "COVID-19, Digitalization, and Firm Productivity: A Tale of MSMEs in Two Industries," India Studies in Business and Economics, Springer, in: Nagesh Kumar & Satyaki Roy, "FDI, MSMEs, Digitalization, and Green Industrialization", DOI: 10.1007/978-981-97-8999-3_7.
• Rachel Glennerster & Thomas Kelly & Claire T. McMahon & Christopher M. Snyder, 2024, "Quantifying the social value of a universal COVID-19 vaccine and incentivizing its development," Review of Economic Design, Springer;Society for Economic Design, volume 28, issue 4, pages 723-761, December, DOI: 10.1007/s10058-024-00363-z.
• Bronwyn H. Hall, 2024, "Patents, innovation, and development," International Review of Applied Economics, Taylor & Francis Journals, volume 38, issue 1-2, pages 17-42, March, DOI: 10.1080/02692171.2021.2022295.
• Oner Tulum & William Lazonick, 2024, "Setting Pharmaceutical Drug Prices: What the Medicare Negotiators Need to Know About Innovation and Financialization," Working Papers Series, Institute for New Economic Thinking, number inetwp226, Sep, DOI: 10.36687/inetwp226.
• Richard N. Langlois, 2024, "Edith Penrose: Seeing into the “Insides” of the Firm," Working papers, University of Connecticut, Department of Economics, number 2024-05, Dec.
• Beck Hanno & Prinz Aloys, 2024, "Die Legalisierung von Cannabis in Deutschland," Wirtschaftsdienst, Sciendo, volume 104, issue 2, pages 128-135, February, DOI: 10.2478/wd-2024-0037.
• Malin, Lydia & Schumacher, Simon, 2024, "Pharmaindustrie: Steigender Druck auf dem Arbeitsmarkt. Fachkräftesituation entlang der pharmazeutischen Wertschöpfungskette," IW-Reports, Institut der deutschen Wirtschaft (IW) / German Economic Institute, number 2/2024.

2023

• Zarek Brot-Goldberg & Timothy Layton & Boris Vabson & Adelina Yanyue Wang, 2023, "The Behavioral Foundations of Default Effects: Theory and Evidence from Medicare Part D," American Economic Review, American Economic Association, volume 113, issue 10, pages 2718-2758, October, DOI: 10.1257/aer.20210013.
• Mariana Carrera & Sofia Villas-Boas, 2023, "Generic Aversion and Observational Learning in the Over-the-Counter Drug Market," American Economic Journal: Applied Economics, American Economic Association, volume 15, issue 3, pages 380-410, July, DOI: 10.1257/app.20200867.
• Luca Maini & Fabio Pammolli, 2023, "Reference Pricing as a Deterrent to Entry: Evidence from the European Pharmaceutical Market," American Economic Journal: Microeconomics, American Economic Association, volume 15, issue 2, pages 345-383, May, DOI: 10.1257/mic.20210053.
• Murali Agastya & Oleksii Birulin, 2023, "Optimal Task Scheduling under Adverse Selection and Hidden Actions," American Economic Journal: Microeconomics, American Economic Association, volume 15, issue 2, pages 660-698, May, DOI: 10.1257/mic.20210126.
• Josh Feng & Thomas Hwang & Luca Maini, 2023, "Profiting from Most-Favored-Customer Procurement Rules: Evidence from Medicaid," American Economic Journal: Economic Policy, American Economic Association, volume 15, issue 2, pages 166-197, May, DOI: 10.1257/pol.20200688.
• Michael D. Frakes & Melissa F. Wasserman, 2023, "Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination," American Economic Journal: Economic Policy, American Economic Association, volume 15, issue 3, pages 151-183, August, DOI: 10.1257/pol.20200703.
• Amitabh Chandra & Courtney Coile & Corina Mommaerts, 2023, "What Can Economics Say about Alzheimer's Disease?," Journal of Economic Literature, American Economic Association, volume 61, issue 2, pages 428-470, June, DOI: 10.1257/jel.20211660.
• Agnes Horvath & Adrienn Takacsne Papp & L szl Molnar & Katalin Liptak & Zoltan Musinszki & Klara Szucsne Markovics, 2023, "Climate and Energy Issues of Energy-Intensive Sectors," The AMFITEATRU ECONOMIC journal, Academy of Economic Studies - Bucharest, Romania, volume 25, issue 64, pages 813-813, August.
• Reinhard Ellwanger & Hinnerk Gnutzmann & Piotr Śpiewanowski, 2023, "Cost Pass-Through with Capacity Constraints and International Linkages," Staff Working Papers, Bank of Canada, number 23-16, Mar, DOI: 10.34989/swp-2023-16.
• Kortelainen, Mika & Markkanen, Jaakko & Toivanen, Otto & Siikanen, Markku, 2023, "The Effects of Price Regulation on Pharmaceutical Expenditure and Availability," CEPR Discussion Papers, C.E.P.R. Discussion Papers, number 18497, Oct.
• Jo Seldeslachts & Albert Banal-Estañol & Nuria Boot, 2023, "Mehr gemeinsame Anteilseigner, mehr US-Investoren: Eigentümerstrukturen deutscher Firmen haben sich verändert," DIW Wochenbericht, DIW Berlin, German Institute for Economic Research, volume 90, issue 32, pages 429-436.
• Yin, Nina, 2023, "Pharmaceuticals, incremental innovation and market exclusivity," International Journal of Industrial Organization, Elsevier, volume 87, issue C, DOI: 10.1016/j.ijindorg.2023.102922.
• Dosi, Giovanni & Palagi, Elisa & Roventini, Andrea & Russo, Emanuele, 2023, "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," Journal of Economic Behavior & Organization, Elsevier, volume 212, issue C, pages 564-589, DOI: 10.1016/j.jebo.2023.05.039.
• Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023, "The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets," Journal of Health Economics, Elsevier, volume 90, issue C, DOI: 10.1016/j.jhealeco.2023.102778.
• Snyder, Christopher M. & Hoyt, Kendall & Gouglas, Dimitrios, 2023, "An optimal mechanism to fund the development of vaccines against emerging epidemics," Journal of Health Economics, Elsevier, volume 91, issue C, DOI: 10.1016/j.jhealeco.2023.102795.
• Liebman, Eli & Lawler, Emily C. & Dunn, Abe & Ridley, David B., 2023, "Consequences of a shortage and rationing: Evidence from a pediatric vaccine," Journal of Health Economics, Elsevier, volume 92, issue C, DOI: 10.1016/j.jhealeco.2023.102819.
• Hu, Mei-Ying & Lu, You-Xun & Lai, Ching-chong, 2023, "Patent term extensions and commercialization lags in the pharmaceutical industry: A growth-theoretic analysis," Journal of Macroeconomics, Elsevier, volume 76, issue C, DOI: 10.1016/j.jmacro.2023.103519.
• Aggarwal, Mayank & Chakrabarti, Anindya S. & Chatterjee, Chirantan & Higgins, Matthew J., 2023, "Research and market structure: Evidence from an antibiotic-resistant pathogenic outbreak," Research Policy, Elsevier, volume 52, issue 1, DOI: 10.1016/j.respol.2022.104633.
• Yousaf, Imran & Pham, Linh & Goodell, John W., 2023, "Interconnectedness between healthcare tokens and healthcare stocks: Evidence from a quantile VAR approach," International Review of Economics & Finance, Elsevier, volume 86, issue C, pages 271-283, DOI: 10.1016/j.iref.2023.03.013.
• Dosi, Giovanni & Marengo, Luigi & Staccioli, Jacopo & Virgillito, Maria Enrica, 2023, "Big Pharma and monopoly capitalism: A long-term view," Structural Change and Economic Dynamics, Elsevier, volume 65, issue C, pages 15-35, DOI: 10.1016/j.strueco.2023.01.004.
• Boutillier, Sophie & Laperche, Blandine & Lebert, Didier & Elouaer-Mrizak, Sana, 2023, "A systemic analysis of the technological trajectory at company level based on patent data: The case of Sanofi's vaccine technology," Technovation, Elsevier, volume 124, issue C, DOI: 10.1016/j.technovation.2023.102746.
• Vipin Valiyattoor & Anup Kumar Bhandari, 2023, "Towards a better measure of productivity in India: a case of chemical and chemical products industry," Indian Growth and Development Review, Emerald Group Publishing Limited, volume 16, issue 2, pages 105-122, March, DOI: 10.1108/IGDR-08-2022-0092.
• Kortelainen, Mika & Markkanen, Jaakko & Siikanen, Markku & Toivanen, Otto, 2023, "The Effects of Price Regulation on Pharmaceutical Expenditure and Availability," Working Papers, VATT Institute for Economic Research, number 157.
• Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023, "The price of cost-effectiveness thresholds," Discussion Paper Series in Economics, Norwegian School of Economics, Department of Economics, number 4/2023, Mar.
• Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023, "Taking the competitor’s pill: when combination therapies enter pharmaceutical markets," Discussion Paper Series in Economics, Norwegian School of Economics, Department of Economics, number 19/2023, Nov.
• Moges Tufa & Mans Söderbom & Zerayehu Sime, 2023, "The Impact of Sector-Specific Industrial Policy on Manufacturing Firm Performance: Quasi-experimental Evidence from Ethiopian Chemical Industries," Journal of Industry, Competition and Trade, Springer, volume 23, issue 3, pages 363-397, December, DOI: 10.1007/s10842-023-00408-z.
• Sang-Min Park & Nicholas S. Vonortas, 2023, "Translational research: from basic research to regional biomedical entrepreneurship," Small Business Economics, Springer, volume 60, issue 4, pages 1761-1783, April, DOI: 10.1007/s11187-022-00676-9.
• Benjamin Jones & Josh Lerner, 2023, "Entrepreneurship and Innovation Policy and the Economy, volume 2," NBER Books, National Bureau of Economic Research, Inc, number lern-15, January.
• Daron Acemoglu, 2023, "Distorted Innovation: Does the Market Get the Direction of Technology Right?," NBER Working Papers, National Bureau of Economic Research, Inc, number 30922, Feb.
• Josh Feng & Matthew J. Higgins & Elena Patel, 2023, "Pediatric Drug Adherence and Parental Attention: Evidence from Comprehensive Claims Data," NBER Working Papers, National Bureau of Economic Research, Inc, number 30968, Feb.
• Alexander P. Frankel & Joshua L. Krieger & Danielle Li & Dimitris Papanikolaou, 2023, "Evaluation and Learning in R&D Investment," NBER Working Papers, National Bureau of Economic Research, Inc, number 31290, May.
• Eli B. Liebman & Emily C. Lawler & Abe Dunn & David B. Ridley, 2023, "Consequences of a Shortage and Rationing: Evidence from a Pediatric Vaccine," NBER Working Papers, National Bureau of Economic Research, Inc, number 31479, Jul.
• Kurt R. Brekke & Odd Rune Straume & Dag Morten Dalen, 2023, "Taking the competitor´s pill: when combination therapies enter pharmaceutical markets," NIPE Working Papers, NIPE - Universidade do Minho, number 12/2023.
• Andrew Brown & Frithjof Laubinger & Peter Börkey, 2023, "Monitoring trade in plastic waste and scrap 2023," OECD Environment Working Papers, OECD Publishing, number 210, Mar, DOI: 10.1787/39058031-en.
• Andrew Brown & Frithjof Laubinger & Peter Börkey, 2023, "New Aspects of EPR: Extending producer responsibility to additional product groups and challenges throughout the product lifecycle," OECD Environment Working Papers, OECD Publishing, number 225, Nov, DOI: 10.1787/cfdc1bdc-en.
• Yves-Marie Rault-Chodankar & Dinar Kale, 2023, "‘Manufacturers without factories’ and economic development in the Global South: India’s pharmaceutical firms," Journal of Economic Geography, Oxford University Press, volume 23, issue 2, pages 319-341.
• Rachel Glennerster & Christopher M. Snyder & Brandon Joel Tan, 2023, "Calculating the Costs and Benefits of Advance Preparations for Future Pandemics," IMF Economic Review, Palgrave Macmillan;International Monetary Fund, volume 71, issue 3, pages 611-648, September, DOI: 10.1057/s41308-023-00212-z.
• Yongwon Cho, 2023, "Impact on the Plant Industry in Korea Caused by Oil Companies’ Entry into the Petrochemical Market," Industrial Economic Review, Korea Institute for Industrial Economics and Trade, number 19-13, Jan.
• Eun Kyo Cho & Woojung Shim, 2023, "The Battle Over Batteries: Chinese Ascendancy and Challenges for Korea," Research Papers, Korea Institute for Industrial Economics and Trade, number 23/1, Jan.
• Gazi Salah Uddin & Muhammad Yahya & Stelios Bekiros & Raanadeva Jayasekera & Gerhard Kling, 2023, "Systematic risk in the biopharmaceutical sector: a multiscale approach," Annals of Operations Research, Springer, volume 330, issue 1, pages 243-266, November, DOI: 10.1007/s10479-021-04402-8.
• Subhrabaran Das & Ariful Hoque, 2023, "Firm-level productivity and its determinants in the Indian pharmaceutical industry," DECISION: Official Journal of the Indian Institute of Management Calcutta, Springer;Indian Institute of Management Calcutta, volume 50, issue 4, pages 439-459, December, DOI: 10.1007/s40622-023-00369-6.
• Ali Faridzad & Mahta Ghafarian Ghadim, 2023, "CO2 intensity decomposition analysis in the Netherlands' manufacturing industry: an application of monetary and physical indicators," Environment, Development and Sustainability: A Multidisciplinary Approach to the Theory and Practice of Sustainable Development, Springer, volume 25, issue 8, pages 8799-8817, August, DOI: 10.1007/s10668-022-02423-2.
• Tobias Basse & Christoph Schwarzbach & J.-Matthias Schulenburg, 2023, "Dividend policy issues in the European pharmaceutical industry: new empirical evidence," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 24, issue 5, pages 803-816, July, DOI: 10.1007/s10198-022-01510-5.
• YongChan Kim & Erdal Atukeren & Yeon W. Lee, 2023, "Digital Double Diamond (DiDD) Model Analysis of National Competitiveness Under Digital Transformation: An Application to Healthcare and Pharmaceutical Industries in South Korea and Switzerland," International Journal of Global Business and Competitiveness, Springer, volume 18, issue 1, pages 1-18, December, DOI: 10.1007/s42943-023-00080-4.
• Aruna Pain & Indrani Chakraborty, 2023, "What Factors are Driving R&D in the Pharmaceutical Industry in India? A Study of the Post-Liberalization Period," Journal of Quantitative Economics, Springer;The Indian Econometric Society (TIES), volume 21, issue 3, pages 617-640, September, DOI: 10.1007/s40953-023-00353-y.
• Sharat Ganapati & Rebecca McKibbin, 2023, "Markups and Fixed Costs in Generic and Off-Patent Pharmaceutical Markets," The Review of Economics and Statistics, MIT Press, volume 105, issue 6, pages 1606-1614, November, DOI: 10.1162/rest_a_01130.
• Dubois, Pierre & Majewska, Gosia & Reig, Valentina, 2023, "Drug Shortages: Empirical Evidence from France," TSE Working Papers, Toulouse School of Economics (TSE), number 23-1417, Mar.
• Klaus Gugler & Florian Szücs, 2023, "Market Power and Regulation in Pharmaceutical Markets," Department of Economics Working Papers, Vienna University of Economics and Business, Department of Economics, number wuwp343, Jul.
• Gugler, Klaus & Szücs, Florian, 2023, "Market Power and Regulation in Pharmaceutical Markets," Department of Economics Working Paper Series, WU Vienna University of Economics and Business, number 343, Jul.
• Dubois, P.; & Majewska, G.; & Reig, V.;, 2023, "Drug Shortages: Empirical Evidence from France," Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York, number 23/07, Aug.
• Mayimele, Nsovo & Demana, Patrick & Keele, Mothobi, 2023, "An assessment of positions, perceptions and valued leadership competencies of pharmacists that work in manufacturing pharmaceutical companies (MPCs) in South Africa," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, volume 7, issue 4, pages 66-79, DOI: 10.61093/sec.7(4).66-79.2023.
• Nyeleti Mayimele, Nsovo & Hulisani Demana, Patrick & Godfrey Keele, Mothobi, 2023, "Pharmacists as Strategic Leaders of Manufacturing Pharmaceutical Companies with Operations in South Africa," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, volume 7, issue 4, pages 200-209, DOI: 10.61093/bel.7(4).200-209.2023.
• Haag, Maike & Kohlisch, Enno & Koppel, Oliver, 2023, "China auf dem Weg zur führenden Technologienation: Analyse der Patentaktivität Chinas sowie ausgewählter Schlüsseltechnologien und -branchen des 14. Fünfjahresplans," IW-Reports, Institut der deutschen Wirtschaft (IW) / German Economic Institute, number 53/2023.
• Kirchhoff, Jasmina & Schumacher, Simon, 2023, "Ökonomische Folgen der Energiepreiskrise am Beispiel der pharmazeutischen Industrie in Deutschland
  [The economic consequences of the energy price crisis as exemplified by the pharmaceutical industry in Germany]," IW-Trends – Vierteljahresschrift zur empirischen Wirtschaftsforschung, Institut der deutschen Wirtschaft (IW) / German Economic Institute, volume 50, issue 2, pages 97-114, DOI: 10.2373/1864-810X.23-02-06.

2022

• Bradley T. Shapiro, 2022, "Promoting Wellness or Waste? Evidence from Antidepressant Advertising," American Economic Journal: Microeconomics, American Economic Association, volume 14, issue 2, pages 439-477, May, DOI: 10.1257/mic.20190277.
• Leila Agha & Dan Zeltzer, 2022, "Drug Diffusion through Peer Networks: The Influence of Industry Payments," American Economic Journal: Economic Policy, American Economic Association, volume 14, issue 2, pages 1-33, May, DOI: 10.1257/pol.20200044.
• Alberto Galasso & Hong Luo, 2022, "When Does Product Liability Risk Chill Innovation? Evidence from Medical Implants," American Economic Journal: Economic Policy, American Economic Association, volume 14, issue 2, pages 366-401, May, DOI: 10.1257/pol.20190757.
• Mary F. Evans & Matthew C. Harris & Lawrence M. Kessler, 2022, "The Hazards of Unwinding the Prescription Opioid Epidemic: Implications for Child Maltreatment," American Economic Journal: Economic Policy, American Economic Association, volume 14, issue 4, pages 192-231, November, DOI: 10.1257/pol.20200301.
• Tal Gross & Timothy J. Layton & Daniel Prinz, 2022, "The Liquidity Sensitivity of Healthcare Consumption: Evidence from Social Security Payments," American Economic Review: Insights, American Economic Association, volume 4, issue 2, pages 175-190, June, DOI: 10.1257/aeri.20200830.
• Leila Agha & Soomi Kim & Danielle Li, 2022, "Insurance Design and Pharmaceutical Innovation," American Economic Review: Insights, American Economic Association, volume 4, issue 2, pages 191-208, June, DOI: 10.1257/aeri.20210063.
• Andrew W. Lo & Richard T. Thakor, 2022, "Financing Biomedical Innovation," Annual Review of Financial Economics, Annual Reviews, volume 14, issue 1, pages 231-270, November, DOI: 10.1146/annurev-financial-031721-08.
• Congressional Budget Office, 2022, "Prescription Drugs: Spending, Use, and Prices," Reports, Congressional Budget Office, number 57050, Jan.
• Kurt R. Brekke & Chiara Canta & Odd Rune Straume, 2022, "Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform," CESifo Working Paper Series, CESifo, number 9853.
• Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulman & Deniz Ünal, 2022, "Industrie pharmaceutique européenne : quand rentabilité rime avec vulnérabilité," La Lettre du CEPII, CEPII research center, issue 423.
• Yang, Ann Shawing & Yulianto, Fritz Andryan, 2022, "Cost of equity and corporate social responsibility for environmental sensitive industries: Evidence from international pharmaceutical and chemical firms," Finance Research Letters, Elsevier, volume 47, issue PA, DOI: 10.1016/j.frl.2021.102532.
• Dewatripont, Mathias, 2022, "Which policies for vaccine innovation and delivery in Europe?," International Journal of Industrial Organization, Elsevier, volume 84, issue C, DOI: 10.1016/j.ijindorg.2022.102858.
• Clark, Robert & Fabiilli, Christopher & Lasio, Laura, 2022, "Collusion in the US generic drug industry," International Journal of Industrial Organization, Elsevier, volume 85, issue C, DOI: 10.1016/j.ijindorg.2022.102878.
• Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2022, "Paying for pharmaceuticals: uniform pricing versus two-part tariffs," Journal of Health Economics, Elsevier, volume 83, issue C, DOI: 10.1016/j.jhealeco.2022.102613.
• Nishimura, Junichi & Nagaoka, Sadao & Yoneyama-Hirozane, Mariko, 2022, "The impact of science-intensive drugs on longevity and cure rate: Evidence from new prescription drugs launched in Japan," Journal of the Japanese and International Economies, Elsevier, volume 64, issue C, DOI: 10.1016/j.jjie.2022.101203.
• Khalifa, Mariem & Trabelsi, Samir & Matoussi, Hamadi, 2022, "Leverage, R&D expenditures, and accounting conservatism: Evidence from technology firms," The Quarterly Review of Economics and Finance, Elsevier, volume 84, issue C, pages 285-304, DOI: 10.1016/j.qref.2022.02.002.
• Branstetter, Lee & Chatterjee, Chirantan & Higgins, Matthew J., 2022, "Generic competition and the incentives for early-stage pharmaceutical innovation," Research Policy, Elsevier, volume 51, issue 10, DOI: 10.1016/j.respol.2022.104595.
• Md. Musfiqur Rahman & Md. Shuvo Howlader, 2022, "The impact of research and development expenditure on firm performance and firm value: evidence from a South Asian emerging economy," Journal of Applied Accounting Research, Emerald Group Publishing Limited, volume 23, issue 4, pages 825-845, May, DOI: 10.1108/JAAR-07-2021-0196.
• Etienne Billette de Villemeur & Jack Scannell & Bruno Versaevel, 2022, "Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?," Post-Print, HAL, number hal-03967759, Nov, DOI: 10.1016/j.drudis.2022.08.001.
• Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2022, "Competing with precision: incentives for developing predictive biomarker tests," Discussion Paper Series in Economics, Norwegian School of Economics, Department of Economics, number 6/2022, Mar.
• Samira Guennif, 2022, "Capture and passive predation in times of COVID-19 pandemic," Public Choice, Springer, volume 193, issue 3, pages 163-186, December, DOI: 10.1007/s11127-022-01005-0.
• David Granlund, 2022, "The Price Effects of Competition from Parallel Imports and Therapeutic Alternatives: Using Dynamic Models to Estimate the Causal Effect on the Extensive and Intensive Margins," Review of Industrial Organization, Springer;The Industrial Organization Society, volume 60, issue 1, pages 63-92, February, DOI: 10.1007/s11151-021-09834-x.
• Amanda Starc & Thomas G. Wollmann, 2022, "Does Entry Remedy Collusion? Evidence from the Generic Prescription Drug Cartel," NBER Working Papers, National Bureau of Economic Research, Inc, number 29886, Mar.
• Katharina E. Blankart & Frank R. Lichtenberg, 2022, "The Effects of Off-label Drug Use on Disability and Medical Expenditure," NBER Working Papers, National Bureau of Economic Research, Inc, number 30440, Sep.
• Richard G. Frank & Andrew L. Hicks & Ernst R. Berndt, 2022, "Auditing the Prescription Drug Consumer Price Index in a Changing Marketplace," NBER Working Papers, National Bureau of Economic Research, Inc, number 30448, Sep.
• Rachel Glennerster & Christopher M. Snyder & Brandon Joel Tan, 2022, "Calculating the Costs and Benefits of Advance Preparations for Future Pandemics," NBER Working Papers, National Bureau of Economic Research, Inc, number 30565, Oct.
• Andrew W. Lo & Richard T. Thakor, 2022, "Financial Intermediation and the Funding of Biomedical Innovation: A Review," NBER Working Papers, National Bureau of Economic Research, Inc, number 30594, Oct.
• Christopher M. Snyder & Kendall Hoyt & Dimitrios Gouglas, 2022, "An Optimal Mechanism to Fund the Development of Vaccines Against Emerging Epidemics," NBER Working Papers, National Bureau of Economic Research, Inc, number 30619, Nov.
• Ivanova, N. & Mamedyarov, Z., 2022, "Pharmaceutical industry in Russia: Key trends and developments," Journal of the New Economic Association, New Economic Association, volume 53, issue 1, pages 248-255, DOI: 10.31737/2221-2264-2022-53-1-15.
• Milena Filipova & Yulia Nedelcheva, 2022, "Value-Added Chain Of A New Pharmaceutical Product," Economics and Management, Faculty of Economics, SOUTH-WEST UNIVERSITY "NEOFIT RILSKI", BLAGOEVGRAD, volume 19, issue 1, pages 65-78, DOI: 10.37708/em.swu.v19i1.6.